We’re delighted to present our latest Annual Report, which provides a summary of CIRS projects, publications and workshops undertaken last year as well as case studies depicting CIRS’ impact in supporting the establishment of the African Medicines Agency and promoting stakeholder interactions to facilitate regulatory-HTA alignment.
CIRS has a rich history of helping to improve the regulatory and access landscape through its work in the areas of metrics, quality and alignment. As regulatory science continues to evolve, we will look to build on these areas but with the background of changes accelerated during the COVID-19 pandemic that have been facilitating medicines development and review.
